<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04320407</url>
  </required_header>
  <id_info>
    <org_study_id>CAM5778</org_study_id>
    <nct_id>NCT04320407</nct_id>
  </id_info>
  <brief_title>Osia CPT Code Study</brief_title>
  <official_title>A Post-market Interventional Cohort Study Evaluating the Clinical Efficacy of the Osia 2 System in the US Market.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cochlear</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cochlear</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the clinical efficacy of the Osia 2 system in patients with conductive or mixed&#xD;
      conductive hearing loss in a US cohort.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">September 30, 2020</start_date>
  <completion_date type="Anticipated">November 30, 2021</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Adaptive speech in noise test for Osia 2 system.</measure>
    <time_frame>3 months</time_frame>
    <description>To demonstrate significant difference between the aided and unaided conditions in Osia 2 arm at 3 months using an adaptive speech in noise test when compared to the preoperative (Visit 1) unaided condition.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">20</enrollment>
  <condition>Conductive Hearing Loss</condition>
  <condition>Mixed Hearing Loss</condition>
  <arm_group>
    <arm_group_label>Osia 2 System</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Osia 2 Active Osseointegrated Implant System for Bone Conduction</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Osia 2 System</intervention_name>
    <description>The external Sound Processor, Osia 2 Active Osseointegrated Implant System for Bone Conduction, captures and digitizes the sound which is transferred to the internal implant where it is converted to an electrical signal.&#xD;
Reference device for Cohort 1 Osia: Baha 5 Power sound processor on the Baha Sound Arc.</description>
    <arm_group_label>Osia 2 System</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Cohort 1 Osia:&#xD;
&#xD;
               -  Willing and able to provide written informed consent.&#xD;
&#xD;
               -  Proficient in English.&#xD;
&#xD;
               -  Hearing loss etiology of Conductive or Mixed Conductive loss.&#xD;
&#xD;
               -  Bone conduction PTA (.5, 1, 2, and 3 kHz) better than or equal to 55 dB HL in the&#xD;
                  treatment ear.&#xD;
&#xD;
               -  Aged 18 years and older.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Cohort 1 Osia:&#xD;
&#xD;
               -  Unwilling to wear the treatment device or comply with the surgical and&#xD;
                  rehabilitation requirements of the study.&#xD;
&#xD;
               -  Unable or unwilling to comply with the requirements of the clinical investigation&#xD;
                  as determined by the Investigator.&#xD;
&#xD;
               -  Medical, audiological or psychological conditions, as judged by the investigator&#xD;
                  that might contraindicate participation in the clinical investigation.&#xD;
&#xD;
               -  Investigator site personnel directly affiliated with this study and/or their&#xD;
                  immediate families; immediate family is defined as a spouse, parent, child, or&#xD;
                  sibling.&#xD;
&#xD;
               -  Cochlear employees or contractors engaged by Cochlear for the purposes of this&#xD;
                  investigation.&#xD;
&#xD;
               -  Currently participating, or participated within the last 30 days, in another&#xD;
                  interventional clinical investigation/trial involving an investigational drug or&#xD;
                  device.&#xD;
&#xD;
               -  Prior experience with a surgical bone conduction treatment option&#xD;
&#xD;
               -  Insufficient bone quality to support the BI300 implant as determined by the&#xD;
                  surgeon&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mark Syms, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Arizona Hearing Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Arizona Ear Center</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Neurosciences</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85718</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University of Michigan</name>
      <address>
        <city>Ann Arbor</city>
        <state>Michigan</state>
        <zip>48109-5312</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Center for Hearing and Balance</name>
      <address>
        <city>Chesterfield</city>
        <state>Missouri</state>
        <zip>63017</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>March 23, 2020</study_first_submitted>
  <study_first_submitted_qc>March 23, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">March 25, 2020</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>conductive hearing loss</keyword>
  <keyword>mixed hearing loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hearing Loss</mesh_term>
    <mesh_term>Deafness</mesh_term>
    <mesh_term>Hearing Loss, Conductive</mesh_term>
    <mesh_term>Hearing Loss, Mixed Conductive-Sensorineural</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Cochlear do not have an approved platform for public sharing of IPD collected in this study. Data may be provided to individual researchers on request</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

